Shopping Cart
Remove All
Your shopping cart is currently empty
Elopiprazole
Copy Product Info
🥰Excellent
Catalog No. T68063Cas No. 115464-77-2
Alias DU 29840
Elopiprazole(DU 29840) is an anti-neurological compound that can be used to study neurological disorders.
Elopiprazole
Copy Product Info🥰Excellent
Purity: 99.53%
Catalog No. T68063Alias DU 29840Cas No. 115464-77-2
Elopiprazole(DU 29840) is an anti-neurological compound that can be used to study neurological disorders.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $55 | In Stock | In Stock | |
| 5 mg | $133 | In Stock | In Stock | |
| 10 mg | $202 | In Stock | In Stock | |
| 25 mg | $386 | In Stock | In Stock | |
| 50 mg | $517 | In Stock | In Stock | |
| 100 mg | $805 | In Stock | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.53%
Appearance:Solid
Color:Yellow
Contact us for more batch information
Product Introduction
Elopiprazole AI Summary
Elopiprazole is a multifaceted bioactive molecule with several notable pharmacological properties. It exhibits a high affinity for the dopamine receptor D2 with a Ki value of 0.45 nM and a moderate binding affinity for the 5-hydroxytryptamine 2 receptors, with a Ki value of 120.0 nM. Additionally, it shows moderate potency in displacing [3H]-WB-4101 from alpha-1 adrenergic receptors (Ki of 220.0 nM) and for the 5-hydroxytryptamine 1A receptor (Ki of 1.5 nM).
In behavioral assays, Elopiprazole displays dose-dependent antagonism of apomorphine-induced climbing behavior in mice, with an ED50 of 2.3 mg/kg for both peroral and intraperitoneal administration. It also suppresses conditioned avoidance behavior in rats following oral administration (ED50 = 2.5 mg/kg) and intraperitoneal administration (ED50 = 5.4 mg/kg). However, it only induces catalepsy in rats at a much higher dose, with an ED50 > 54.0 mg/kg intraperitoneally.
Moreover, the compound shows antiviral activity against the SARS-CoV-2 virus (USA-WA1/2020 isolate) with an EC50 value of 1100.0 nM after 24 hours in Vero E6 cells, highlighting its potential as an antiviral agent. It also displays a Na+ ratio of 2.0, reflecting its differential activity in the presence of sodium ions. Overall, Elopiprazole has significant potential in both neurological and antiviral therapeutic applications..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Elopiprazole(DU 29840) is an anti-neurological compound that can be used to study neurological disorders. |
| Synonyms | DU 29840 |
| Molecular Weight | 375.44 |
| Formula | C23H22FN3O |
| Cas No. | 115464-77-2 |
| Smiles | C(N1CCN(C2=C3C(=CC=C2)C=CO3)CC1)C=4NC(=CC4)C5=CC=C(F)C=C5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (133.18 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy Elopiprazole | purchase Elopiprazole | Elopiprazole cost | order Elopiprazole | Elopiprazole chemical structure | Elopiprazole formula | Elopiprazole molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.